SRNE at $1.90 -- Target Price Issued at $20! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRNE at $1.90 -- Target Price Issued at $20!

SRNE 0.00780

+2.6%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: albertaft	7/15/2017 8:49:36 AM
	of 4

I've been still doing a lot of research on SRNE. What's interesting is that they completed Phase III trials in China on a few different drug therapies for cancer, and in May they announced the completion of building a very Manufacturing Plant in China. It would appear that Sorrento has partnered with the Chinese and big things are happening. This does not include their various drugs going though trials in the U.S. in which they are now entering Phase III trials. I can see why they are giving SRNE at $2.00 with very high target prices of $20 - $30. These target prices are legit and any basic research will reveal it - and the forecasts by reputable Analysts. Institutional investors include BofA? As Trump would say - It's gonna be HUGE. lol

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next